Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,786,053 papers from all fields of science
Search
Sign In
Create Free Account
metmyoglobin azide
Known as:
azidometmyoglobin
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Metmyoglobin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
Free fatty acids enhance the oxidation of oxymyoglobin and inhibit the peroxidase activity of metmyoglobin.
J. Stewart
Biochemistry and cell biology = Biochimie et…
1990
Corpus ID: 25947327
The effect of low concentrations of sodium oleate on the oxidation of oxymyoglobin to metmyoglobin has been examined. This long…
Expand
1986
1986
Adiabatic compressibility of myoglobin. Effect of axial ligand and denaturation.
W. Leung
,
K. Cho
,
Y. Lo
,
C. Choy
Biochimica et Biophysica Acta
1986
Corpus ID: 7813969
1983
1983
Kinetic studies on the reduction of metmyoglobins by ascorbic acid.
K. Tsukahara
,
Y. Yamamoto
Journal of Biochemistry (Tokyo)
1983
Corpus ID: 45097176
The kinetics of the reduction of metmyoglobins by ascorbic acid (H2A) were studied under a nitrogen atmosphere at 25 degrees C…
Expand
Highly Cited
1979
Highly Cited
1979
Low-frequency vibrations in resonance Raman spectra of horse heart myoglobin. Iron-ligand and iron-nitrogen vibrational modes.
A. Desbois
,
M. Lutz
,
R. Banerjee
Biochemistry
1979
Corpus ID: 22675081
The low-frequency regions (150--700 cm-1) of resonance Raman (RR) spectra of various complexes of oxidized and reduced horse…
Expand
1973
1973
Heme-modification studies of myoglobin. II. Ligand binding characteristics of ferric and ferrous myoglobins containing unnatural hemes.
M. Tamura
,
G. Woodrow
,
T. Yonetani
Biochimica et Biophysica Acta
1973
Corpus ID: 36911623
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE